Behavioural activation showed no clear difference in treatment acceptabilityup to 6 months (16 weeks) compared with placebo (low certainty).
The review found no eligible studies for this question.
It is very uncertain whether client feedback changes treatment acceptability: dropouts from treatment compared with no client feedback (very low certainty).
Endometrial resection or ablation probably leads to lower acceptability Proportion satisfied with treatment compared with minimally invasive hysterectomy (moderate certainty).
Endometrial resection/ablation showed no clear difference in acceptability Proportion satisfied with treatment compared with unspecified (or at surgeon's discretion) route of hysterectomy (moderate certainty).
Endometrial resection or ablation showed no clear difference in acceptability Proportion satisfied with treatment compared with open hysterectomy (moderate certainty).
Behavioural activation showed no clear difference in treatment acceptabilityup to 6 months (2‐5 weeks) compared with no treatment (moderate certainty).
It is very uncertain whether behavioural activation changes treatment acceptabilityup to 6 months (2‐10 weeks) compared with humanistic therapy (very low certainty).
It is very uncertain whether behavioural activation changes treatment acceptabilityup to 6 months (4‐12 weeks) compared with interpersonal, cognitive analytic, integrative (very low certainty).
Behavioural activation showed no clear difference in treatment acceptabilityup to 6 months (5‐12 weeks) compared with treatment (moderate certainty).
Behavioural activation showed no clear difference in treatment acceptability up to 6 months (4‐8 weeks) compared with third‐wave CBT (low certainty).
It is very uncertain whether amitriptyline changes acceptability of treatment Drop‐out for any reason compared with placebo (very low certainty).
Behavioural activation showed no clear difference in treatment acceptability up to 6 months (4‐16 weeks) compared with CBT (low certainty).
Behavioural activation showed no clear difference in treatment acceptabilityup to 6 months (12‐16 weeks) compared with medication (moderate certainty).
Antidepressants plus benzodiazepines showed no clear difference in acceptability of treatment (dropout for any reason) compared with antidepressants alone (moderate certainty).
It is very uncertain whether the intervention changes acceptability of treatment: Leaving the study early (very low certainty).
It is very uncertain whether CHOLINERGIC DRUGS changes acceptability of treatment: Leaving the study early compared with PLACEBO (very low certainty).
It is very uncertain whether DOPAMINERGIC DRUGS changes acceptability of treatment: Leaving the study early compared with PLACEBO (very low certainty).
It is very uncertain whether DOPAMINERGIC DRUGS changes acceptability of treatment: Leaving the study early compared with OTHER DRUGS (very low certainty).